Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
aggressive cancer
Research
Drug combo treats cancers with ‘paradox’ mutation in mice
Mutations in BAP1 can promote cancer development or lead to less aggressive forms of the disease, depending on the circumstances.
Darren Incorvaia
Apr 1, 2026 2:00pm
Sophia Genetics, AstraZeneca partner to improve oncology trials
Feb 14, 2023 3:15pm
Vial reels in $67M in series B fund raising; adds NEXT Oncology
Nov 30, 2022 3:11pm
OncoBay signs on with physIQ’s latest clinical trial program
Nov 17, 2022 10:13am
Massive Bio, Azra AI partner to boost cancer trial enrollment
Nov 14, 2022 12:58pm
Massive Bio expands European operations with 3 new hires
Sep 28, 2022 10:48pm
